Table 3.

Impact of the association of AO with elevated TNF-α after adjusting for their covariates in a representative sample of the study subjects

Variables	Type 2 diabetes mellitus
	OR	95 % CI	p value
(A)
Elevated TNF-α	1.79	1.09–2.97	0.022
Insulin resistance	3.15	1.88–5.27	<0.001
Increased MDA	1.61	1.10–2.36	0.013
Increased TG	1.08	0.72–1.62	0.701
Reduced HDL	1.22	0.79–1.90	0.374
Abdominal obesity	1.75	1.03–2.97	0.040
Age	0.99	0.97–1.01	0.410
(B)
Elevated IL6	1.74	1.04–2.91	0.033
Insulin resistance	3.12	1.91–5.10	<0.001
Increased MDA	1.84	1.26–2.68	0.002
Increased TG	1.13	0.75–1.69	0.557
Reduced HDL	1.32	0.85–2.05	0.224
Abdominal obesity	1.96	1.16–3.29	0.011
Age	0.99	0.97–1.01	0.207
(C)
Elevated hs-CRP	1.79	1.08–2.95	0.023
Insulin resistance	2.07	1.28–3.34	0.003
Increased MDA	1.58	1.08–2.29	0.017
Increased TG	1.17	0.78–1.74	0.443
Reduced HDL	1.23	0.79–1.91	0.351
Abdominal obesity	2.12	1.25–3.60	0.005
Age	0.99	0.97–1.00	0.140

Model after adjusted for insulin resistance, reduced HDL, reduced TAC and age